BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 35605744)

  • 1. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.
    Staufer K; Huber-Schönauer U; Strebinger G; Pimingstorfer P; Suesse S; Scherzer TM; Paulweber B; Ferenci P; Stimpfl T; Yegles M; Datz C; Trauner M
    J Hepatol; 2022 Oct; 77(4):918-930. PubMed ID: 35605744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease.
    Morinaga M; Kon K; Uchiyama A; Fukada H; Fukuhara K; Yaginuma R; Nakadera E; Yamashina S; Ikejima K
    Hepatol Int; 2022 Apr; 16(2):348-358. PubMed ID: 35060066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports.
    Wurst FM; Dürsteler-MacFarland KM; Auwaerter V; Ergovic S; Thon N; Yegles M; Halter C; Weinmann W; Wiesbeck GA
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1552-7. PubMed ID: 18616663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Ethyl Glucuronide in Hair for Detection of Alcohol Consumption in Patients After Liver Transplantation.
    Andresen-Streichert H; von Rothkirch G; Vettorazzi E; Mueller A; Lohse AW; Frederking D; Seegers B; Nashan B; Sterneck M
    Ther Drug Monit; 2015 Aug; 37(4):539-45. PubMed ID: 25525763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hair ethyl glucuronide and serum carbohydrate deficient transferrin for the assessment of relapse in alcohol-dependent patients.
    Crunelle CL; Verbeek J; Dom G; Covaci A; Yegles M; Michielsen P; De Doncker M; Nevens F; Cappelle D; van Nuijs AL; Neels H
    Clin Biochem; 2016 May; 49(7-8):554-9. PubMed ID: 26851349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study.
    Andresen-Streichert H; Beres Y; Weinmann W; Schröck A; Müller A; Skopp G; Pischke S; Vettorazzi E; Lohse A; Nashan B; Sterneck M
    Transpl Int; 2017 Jun; 30(6):611-620. PubMed ID: 28295675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption.
    Staufer K; Andresen H; Vettorazzi E; Tobias N; Nashan B; Sterneck M
    Hepatology; 2011 Nov; 54(5):1640-9. PubMed ID: 21809364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of health checkup for screening metabolic dysfunction-associated fatty liver disease and alcohol-related liver disease in Japanese male young adults.
    Tajirika S; Miwa T; Francisque C; Hanai T; Imamura N; Adachi M; Horita R; Menezes LJ; Shimizu M; Yamamoto M
    Sci Rep; 2023 May; 13(1):7987. PubMed ID: 37202437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting alcohol abuse: traditional blood alcohol markers compared to ethyl glucuronide (EtG) and fatty acid ethyl esters (FAEEs) measurement in hair.
    Hastedt M; Büchner M; Rothe M; Gapert R; Herre S; Krumbiegel F; Tsokos M; Kienast T; Heinz A; Hartwig S
    Forensic Sci Med Pathol; 2013 Dec; 9(4):471-7. PubMed ID: 23504201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of Clinical Examination, Self-Report, and Hair Ethyl Glucuronide Analysis for Evaluation of Patients With Alcoholic Liver Disease Prior to Liver Transplantation.
    Beckmann M; Paslakis G; Böttcher M; Helander A; Erim Y
    Prog Transplant; 2016 Mar; 26(1):40-6. PubMed ID: 27136248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of ethyl glucuronide in hair improves evaluation of long-term alcohol abstention in liver transplant candidates.
    Sterneck M; Yegles M; Rothkirch von G; Staufer K; Vettorazzi E; Schulz KH; Tobias N; Graeser C; Fischer L; Nashan B; Andresen-Streichert H
    Liver Int; 2014 Mar; 34(3):469-76. PubMed ID: 23829409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate-deficient transferrin as a marker of alcohol abuse: relationship to alcohol consumption, severity of liver disease, and fibrogenesis.
    Niemelä O; Sorvajärvi K; Blake JE; Israel Y
    Alcohol Clin Exp Res; 1995 Oct; 19(5):1203-8. PubMed ID: 8561291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between serum carbohydrate-deficient transferrin and hair ethyl glucuronide in detecting chronic alcohol consumption in routine.
    Bianchi V; Premaschi S; Raspagni A; Secco S; Vidali M
    Alcohol Alcohol; 2015 May; 50(3):266-70. PubMed ID: 25698630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of MAFLD and NAFLD diagnostic criteria in real world.
    Lin S; Huang J; Wang M; Kumar R; Liu Y; Liu S; Wu Y; Wang X; Zhu Y
    Liver Int; 2020 Sep; 40(9):2082-2089. PubMed ID: 32478487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAFLD and MAFLD as emerging causes of HCC: A populational study.
    Myers S; Neyroud-Caspar I; Spahr L; Gkouvatsos K; Fournier E; Giostra E; Magini G; Frossard JL; Bascaron ME; Vernaz N; Zampaglione L; Negro F; Goossens N
    JHEP Rep; 2021 Apr; 3(2):100231. PubMed ID: 33748726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome.
    Hsu CL; Lang S; Demir M; Fouts DE; Stärkel P; Schnabl B
    Hepatology; 2023 Jun; 77(6):2073-2083. PubMed ID: 36631002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility and prognostic value of diagnosing MAFLD in patients undergoing liver transplantation for alcohol-related liver disease.
    Vanlerberghe BTK; van Malenstein H; Sainz-Bariga M; Jochmans I; Cassiman D; Monbaliu D; van der Merwe S; Pirenne J; Nevens F; Verbeek J
    Clin Transplant; 2023 Jun; 37(6):e14965. PubMed ID: 36940254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of EtG in hair, EtG and EtS in urine and PEth species in capillary dried blood spots to assess the alcohol consumption in driver's licence regranting cases.
    Kummer N; Wille SM; Poll A; Lambert WE; Samyn N; Stove CP
    Drug Alcohol Depend; 2016 Aug; 165():191-7. PubMed ID: 27364378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.